作者:
2018-05-16 14:52來源:中國證券報·中證網
中證網訊(記者(zhe) 董安琪)長(chang)生生物(002680)5月16日在互動平臺(tai)表示,公司(si)四價流(liu)感疫苗在拿到生產批件并通過中檢院(yuan)批簽發即(ji)可(ke)上(shang)市(shi)銷(xiao)(xiao)售(shou),相關準備公司(si)已經就緒。綜合(he)考慮競爭(zheng)格局、保護效果(guo)、市(shi)場認知等(deng)因素,公司(si)對四價流(liu)感疫苗的銷(xiao)(xiao)售(shou)較為樂觀。
中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)網(wang)聲(sheng)明(ming):凡本(ben)(ben)(ben)網(wang)注明(ming)“來源:中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)證(zheng)(zheng)(zheng)(zheng)券(quan)報·中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)網(wang)”的所有作品,版權均屬于(yu)中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)證(zheng)(zheng)(zheng)(zheng)券(quan)報、中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)網(wang)。中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)證(zheng)(zheng)(zheng)(zheng)券(quan)報·中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)網(wang)與作品作者聯(lian)合(he)聲(sheng)明(ming),任(ren)何(he)組(zu)織未經中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)證(zheng)(zheng)(zheng)(zheng)券(quan)報、中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)網(wang)以(yi)及作者書面授權不(bu)得(de)轉載、摘編或利用(yong)其它方式使(shi)用(yong)上述作品。凡本(ben)(ben)(ben)網(wang)注明(ming)來源非中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)證(zheng)(zheng)(zheng)(zheng)券(quan)報·中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)網(wang)的作品,均轉載自(zi)其它媒體,轉載目(mu)的在(zai)于(yu)更好服務讀者、傳(chuan)遞(di)信(xin)息(xi)之需,并(bing)不(bu)代表本(ben)(ben)(ben)網(wang)贊同(tong)其觀點,本(ben)(ben)(ben)網(wang)亦不(bu)對其真實性負責,持異議(yi)者應與原(yuan)出處單位主(zhu)張權利。
2016年度“金牛理財產品”頒獎典...
第二十一屆(2017年度)中國資本...
中水集團遠洋股份有限公司投資者...
特別鏈接:政府部門交易機構證券期貨四所兩司新聞發布平臺友情鏈接版權聲明 關于報社關于本站廣告發布免責條款
中國證券報社版權所有,未經書面授權不得復制或建立鏡像 經營許可證編號:京B2-20180749 京公網安備0-1 Copyright 2001-2018 China Securities Journal. All Rights Reserved
中(zhong)國證券報社(she)版權所有,未(wei)經書面授權不(bu)得復制或建立鏡像
經營許可證編號:京B2-20180749 京公網安備0-1
Copyright 2001-2018 China Securities Journal. All Rights Reserved